当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析 - 现金流量表

西藏药业

(600211)

  

流通市值:129.86亿  总市值:129.86亿
流通股本:3.22亿   总股本:3.22亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,713,071,497.171,816,346,866.251,030,420,360.83,137,352,266.46
  收到的税费返还-33,802.59-1,619,757.68
  收到其他与经营活动有关的现金232,299,194.27200,949,889110,568,691.59141,273,779.01
  经营活动现金流入小计2,945,370,691.442,017,330,557.841,140,989,052.393,280,245,803.15
  购买商品、接受劳务支付的现金223,626,751.68140,214,268.379,889,498.51218,574,565.99
  支付给职工以及为职工支付的现金109,289,443.8980,554,876.7150,868,310.45108,250,964.7
  支付的各项税费330,563,407.19224,514,239.03109,426,338.49379,541,632.58
  支付其他与经营活动有关的现金1,475,615,716.541,092,890,071.21517,353,922.271,569,127,833.96
  经营活动现金流出小计2,139,095,319.31,538,173,455.25757,538,069.722,275,494,997.23
  经营活动产生的现金流量净额806,275,372.14479,157,102.59383,450,982.671,004,750,805.92
二、投资活动产生的现金流量:
  收回投资收到的现金3,886,473,126.492,809,435,209.061,321,000,0004,370,088,463.9
  取得投资收益收到的现金22,279,906.6919,999,0845,271,887.9321,965,343.64
  处置固定资产、无形资产和其他长期资产收回的现金净额4,669.574,612.051,363.2344,274.86
  收到的其他与投资活动有关的现金5,069,684.94--162,484,572.9
  投资活动现金流入小计3,913,827,387.692,829,438,905.111,326,273,251.134,554,882,655.3
  购建固定资产、无形资产和其他长期资产支付的现金17,158,178.646,976,145.123,194,382.2415,957,010.34
  投资支付的现金4,075,029,075.333,272,687,979.431,695,858,801.365,128,000,000
  取得子公司及其他营业单位支付的现金92,000---
  支付其他与投资活动有关的现金-4,086,815.07--
  投资活动现金流出小计4,092,279,253.973,283,750,939.621,699,053,183.65,143,957,010.34
  投资活动产生的现金流量净额-178,451,866.28-454,312,034.51-372,779,932.47-589,074,355.04
三、筹资活动产生的现金流量:
  取得借款收到的现金1,381,500,471.431,022,521,291.83310,000,000960,044,596.77
  收到其他与筹资活动有关的现金16,541,114.0216,541,114.0217,121,130.2149,752,596.6
  筹资活动现金流入小计1,398,041,585.451,039,062,405.85327,121,130.211,009,797,193.37
  偿还债务支付的现金929,034,819.82692,362,514.5250,011,046.56482,043,450.52
  分配股利、利润或偿付利息支付的现金651,832,728.38283,624,280.37887,835.71614,742,807.58
  其中:子公司支付给少数股东的股利、利润1,023,0001,023,000-1,212,200
  支付其他与筹资活动有关的现金177,753,516.09177,717,450.32178,286,147.0735,634,096.33
  筹资活动现金流出小计1,758,621,064.291,153,704,245.21229,185,029.341,132,420,354.43
  筹资活动产生的现金流量净额-360,579,478.84-114,641,839.3697,936,100.87-122,623,161.06
四、汇率变动对现金及现金等价物的影响-56,698,855.3-16,251,799.71-21,090,592.86-22,454,136.39
五、现金及现金等价物净增加额210,545,171.72-106,048,570.9987,516,558.21270,599,153.43
  加:期初现金及现金等价物余额1,576,500,319.481,576,500,319.481,576,500,319.481,305,901,166.05
  期末现金及现金等价物余额1,787,045,491.21,470,451,748.491,664,016,877.691,576,500,319.48
补充资料:
  净利润-571,128,354.71-916,980,955.72
  资产减值准备-3,717,956.24-4,409,036.31
  固定资产和投资性房地产折旧-34,660,527.39-50,681,742.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-34,660,527.39-50,681,742.86
  无形资产摊销-11,062,888.83-28,868,856.29
  长期待摊费用摊销-745,842.65-848,553.86
  处置固定资产、无形资产和其他长期资产的损失-0--108,677.06
  固定资产报废损失--1,284,894.69-27,349.84
  公允价值变动损失-5,092,343.47--1,661,657.85
  财务费用-23,369,940.25-6,655,899.81
  投资损失--10,108,006.18--7,872,352.36
  递延所得税--7,269,460.12-18,866,389.41
  其中:递延所得税资产减少--6,635,255.08-18,528,417.75
    递延所得税负债增加--634,205.04-337,971.66
  存货的减少--13,591,247.95--43,304,388.04
  经营性应收项目的减少-45,706,371.49--195,417,961.86
  经营性应付项目的增加--190,838,786.22-225,408,307.81
  其他-6,315,988.89-368,751.18
  现金的期末余额-1,470,451,748.49-1,576,500,319.48
  减:现金的期初余额-1,576,500,319.48-1,305,901,166.05
  现金及现金等价物的净增加额--106,048,570.99-270,599,153.43
公告日期2026-10-312026-08-142026-04-292026-03-13
审计意见(境内)标准无保留意见
TOP↑